News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Daily News ‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low Michael O'Riordan August 01, 2017
News Daily News Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study Leah Lawrence July 24, 2017
News Daily News Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment Todd Neale July 20, 2017
News Daily News More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis Michael O'Riordan July 03, 2017
News Daily News Poor Prescription Adherence After Acute MI Continues to Vex Researchers L.A. McKeown June 30, 2017
News Daily News CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP Todd Neale June 22, 2017
News Daily News Use of DAPT Score Following PCI Validated in PRODIGY Study Yael L. Maxwell June 12, 2017
News Daily News Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease L.A. McKeown June 12, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017
News Features How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts Michael O'Riordan May 23, 2017
News Daily News Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk Caitlin E. Cox May 15, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Conference News ACC 2017 DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions Yael L. Maxwell March 19, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News 10-Year Follow-up of Early DES Shows Steady Risk of Late Events L.A. McKeown February 08, 2017